루닛: directors' dealings · South Korea · DART (FSS) DART:company-bb3577 KR KR · DART (FSS) Mcap 1338.9Bn€ Healthcare
Explore the full insider trade history of 루닛, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 루닛 has published 24 public disclosures. Market capitalisation: €1,338.9bn. The latest transaction was reported on 8 May 2026 — Purchase. Among the most active insiders: 백승욱. The full history is openly available.
Financial data FY ended December 2025 · cache
Analyst consensus
1 analysts 15000.00 € Target 15000.00 €(-17%) 15000.00 €
Income statement
Revenue 83.13 Bn€
Gross profit 83.13 Bn€ 100% margin
Net income −47.39 Bn€ -57.0% margin
Valuation
PER (forward) -10.7x
Beta 1.31
Balance sheet & cash
Market cap 1338.89 Bn€
Total debt 111.58 Bn€
Free Cash Flow −64.81 Bn€
Debt / Equity 81%
Profitability & ownership
ROE -31.6%
ROA -12.9%
% insiders 33.8%
% institutions 20.2%
Last declaration on 8 May 2026
Declarations 24 total
Executives ● Purchase2 DART
€39m 3,360,487 shares
DART:20260508000609 · 8 May 2026
Ideal exit: 2 Feb 2027 (T+270) Executives ● Purchase11 DART
€304,267 705,829 shares @ €15.4882 0.0000% mcap 42.8% of flow
DART:20260508000577 · 4 May 2026
Ideal exit: 29 Jan 2027 (T+270) Executives ● Purchase11 DART
€9,401 24,321 shares @ €15.4882 0.0000% mcap 40.0% of flow
DART:20260508000600 · 4 May 2026
Ideal exit: 29 Jan 2027 (T+270) Executives ● Purchase11 DART
€54,302 140,402 shares @ €15.4882 0.0000% mcap 40.0% of flow
DART:20260508000593 · 4 May 2026
Ideal exit: 29 Jan 2027 (T+270) Executives ● Purchase11 DART
€40,207 103,944 shares @ €15.4882 0.0000% mcap 40.0% of flow
DART:20260508000584 · 4 May 2026
Ideal exit: 29 Jan 2027 (T+270) Executives ● Sale2 DART
€1m 90,157 shares
DART:20260507000719 · 7 May 2026
Executives ● Purchase2 DART
€3m 243,434 shares
DART:20260413000158 · 13 Apr 2026
Ideal exit: 8 Jan 2027 (T+270) Executives ● Purchase13 DART
€81,525 31,562 shares @ €2.583 0.0000% mcap 60.0% of flow
DART:20260413000103 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) Executives ● Purchase13 DART
€60,354 23,366 shares @ €2.583 0.0000% mcap 60.0% of flow
DART:20260413000093 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) Executives ● Purchase15 DART
€401,610 155,482 shares @ €2.583 0.0000% mcap 100.0% of flow
DART:20260413000067 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) Executives ● Purchase15 DART
€485,721 186,100 shares @ €2.61 0.0000% mcap 100.0% of flow
DART:20260413000055 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase30 DART
€197,783 75,779 shares @ €2.61 0.0000% mcap 100.0% of flow
DART:20260413000050 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase15 DART
€1m 453,691 shares @ €2.61 0.0001% mcap 100.0% of flow
DART:20260413000033 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase13 DART
€14,124 5,468 shares @ €2.583 0.0000% mcap 60.0% of flow
DART:20260413000111 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) Executives ● Purchase13 DART
€407,368 157,711 shares @ €2.583 0.0000% mcap 57.2% of flow
DART:20260413000082 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) Executives ● Purchase15 DART
€344,922 132,154 shares @ €2.61 0.0000% mcap 100.0% of flow
DART:20260413000073 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase2 DART
€16m 1,623,355 shares
DART:20260409002253 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) Executives ● Purchase7 DART
DART:20260403002962 · 3 Apr 2026
Ideal exit: 29 Dec 2026 (T+270) Executives ● Purchase7 DART
DART:20260403003187 · 3 Apr 2026
Ideal exit: 29 Dec 2026 (T+270) Executives ● Purchase7 DART
DART:20260403003161 · 3 Apr 2026
Ideal exit: 29 Dec 2026 (T+270) Executives ● Purchase7 DART
DART:20260403003221 · 3 Apr 2026
Ideal exit: 29 Dec 2026 (T+270) Executives ● Purchase7 DART
DART:20260403003008 · 3 Apr 2026
Ideal exit: 29 Dec 2026 (T+270) Executives ● Purchase7 DART
DART:20260403002871 · 3 Apr 2026
Ideal exit: 29 Dec 2026 (T+270) Executives ● Purchase7 DART
DART:20260403002786 · 3 Apr 2026
Ideal exit: 29 Dec 2026 (T+270)
